Edition:
United States

Insider Trading: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

6,445JPY
1:00am EST
Change (% chg)

¥11 (+0.17%)
Prev Close
¥6,434
Open
¥6,469
Day's High
¥6,515
Day's Low
¥6,435
Volume
904,200
Avg. Vol
978,596
52-wk High
¥7,929
52-wk Low
¥5,366

All Insider Trades

Institutional Holders

% Shares Owned: 43.80%
# of Holders: 248
Total Shares Held: 129,885,989
3 Mo. Net Change: -56,666
# New Positions: 7
# Closed Positions: 3
# Increased Positions: 49
# Reduced Positions: 31
# Net Buyers: 18

Officers & Directors

Name Age Since Current Position

Haruo Naito

68 2014 Chief Executive Officer, Representative Executive Officer, Director

Ryohei Yanagi

53 2015 Managing Executive Officer, Chief Financial Officer, Chief IR Officer

Hideki Hayashi

58 2014 Representative Executive Officer, Chief Information Officer

Junichi Asatani

55 2015 Chief Compliance Officer, Executive Officer

Kenta Takahashi

56 2015 General Counsel, Managing Executive Officer

Takafumi Asano

58 2015 Senior Managing Executive Officer, President of Eisai Demand Chain Systems, President of Stable Brand DCU

Yasushi Okada

57 2014 Senior Managing Executive Officer, Chief Talent Officer, Chief Director of Human Resources Development

Edward Geary

53 2015 Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs

Gary Hendler

49 2014 Managing Executive Officer, President of EMEA Region, President of Eisai Global Oncology Business Unit, President & Chief Executive Officer of Subsidiary

Terushige Iike

52 2015 Managing Executive Officer, Chief Product Creation Officer in Eisai Product Creation Systems, President of Japan/Asia Clinical Research PCU for Eisai Product Creation Systems, President of Subsidiary

Yuji Matsue

56 2014 Managing Executive Officer, President of Americas Region, Chairman & Chief Executive Officer of Subsidiary

Hidenori Yabune

45 2015 Executive Officer, Director of Integrated Marketing in Eisai Japan

Ivan Cheung

39 2015 Executive Officer, Deputy President of Eisai Global Oncology Business Unit, Deputy President of Eisai Global Neurology Business Unit

Frank Ciriello

55 2014 Executive Officer, President of Eisai Global Neurology Business Unit

Yasunobu Kai

54 2013 Executive Officer, President of Eisai Japan Oncology hhc Unit

Teiji Kimura

53 2015 Executive Officer, Director of Global Discovery Research, Deputy President of Neuroscience & General Medicine PCU Unit

Lynn Kramer

65 2015 Executive Officer, Chief Clinical Officer of Eisai Product Creation Systems, Chief Medical Officer of Eisai Global Neurology Business Unit, President of Neuroscience & General Medicine PCU

Kenji Matsumae

60 2015 Executive Officer, President of Eisai Japan

Takashi Ohwa

52 2012 Executive Officer, Chief Innovation Officer of Eisai Product Creation Systems

Shaji Procida

44 2014 Executive Officer, President of Subsidiary

Sayoko Sasaki

47 2015 Executive Officer

Satoru Yasuda

53 2015 Executive Officer, President of Integrated Community hhc Unit in Eisai Japan

Hideshi Honda

61 2014 Representative Executive Officer, President of Asia Region

Yutaka Tsuchiya

63 2014 Representative Executive Officer

Nobuo Deguchi

68 2012 Director

Hideaki Matsui

67 2011 Director

Noboru Naoe

60 2014 Director

Graham Fry

66 2012 Independent Director

Ikuo Nishikawa

65 2014 Independent Director

Kiyochika Ohta

73 2011 Independent Director

Patricia Robinson

53 2013 Independent Director

Eiichiro Suhara

67 2015 Independent Director

Osamu Suzuki

66 2012 Independent Director

Toru Yamashita

68 2014 Independent Director

Hirokazu Kanai

Director of Accounting